| __timestamp | Ligand Pharmaceuticals Incorporated | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 22570000 | 381287000 |
| Thursday, January 1, 2015 | 24378000 | 452612000 |
| Friday, January 1, 2016 | 26621000 | 316800000 |
| Sunday, January 1, 2017 | 28653000 | 330100000 |
| Monday, January 1, 2018 | 37734000 | 265800000 |
| Tuesday, January 1, 2019 | 41884000 | 336200000 |
| Wednesday, January 1, 2020 | 64435000 | 423900000 |
| Friday, January 1, 2021 | 57483000 | 467000000 |
| Saturday, January 1, 2022 | 70062000 | 487000000 |
| Sunday, January 1, 2023 | 52790000 | 477100000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of United Therapeutics Corporation and Ligand Pharmaceuticals Incorporated from 2014 to 2023. Over this period, United Therapeutics consistently outspent Ligand Pharmaceuticals, with SG&A expenses peaking at approximately $487 million in 2022, a staggering 600% more than Ligand's highest expenditure of around $70 million in the same year. Notably, Ligand's expenses saw a significant increase of over 200% from 2014 to 2022, reflecting strategic investments in growth and operations. Meanwhile, United Therapeutics maintained a steady upward trend, underscoring its robust market position. This financial insight not only highlights the contrasting strategies of these two companies but also offers a glimpse into their operational priorities over the past decade.
Comparing SG&A Expenses: GSK plc vs Ligand Pharmaceuticals Incorporated Trends and Insights
Breaking Down SG&A Expenses: United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
United Therapeutics Corporation or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: United Therapeutics Corporation vs MiMedx Group, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Evotec SE
Comparing SG&A Expenses: Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated Trends and Insights
Operational Costs Compared: SG&A Analysis of Lantheus Holdings, Inc. and Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Axsome Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Ligand Pharmaceuticals Incorporated and Mesoblast Limited
Breaking Down SG&A Expenses: Ligand Pharmaceuticals Incorporated vs Novavax, Inc.
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Xencor, Inc.